Julia M. Unglaub

Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax

Alexander Waclawiczek, Aino‐Maija Leppä, Simon Renders et al. · Cancer Discovery · 2023 · 85 citations · Full text

Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia

Christina Rautenberg, Friedrich Stölzel, Christoph Röllig et al. · Blood Cancer Journal · 2021 · 62 citations · Full text

[Distal radius fracture of the adult : Diagnostics and therapy].

Frank Unglaub, Martin Langer, B. Hohendorff et al. · PubMed · 2017 · 14 citations

Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia

David Sedloev, Qian Chen, Julia M. Unglaub et al. · Journal of Hematology & Oncology · 2024 · 10 citations · Full text

Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML

Julia M. Unglaub, Richard F. Schlenk, Jan Moritz Middeke et al. · Blood Advances · 2024 · 10 citations · Full text